BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 23972814)

  • 1. Management of non-small-cell lung cancer: recent developments.
    Reck M; Heigener DF; Mok T; Soria JC; Rabe KF
    Lancet; 2013 Aug; 382(9893):709-19. PubMed ID: 23972814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of early-stage non-small cell lung carcinoma and the present and future roles of adjuvant therapy: a review for the radiation oncologist.
    Medford-Davis L; Decamp M; Recht A; Flickinger J; Belani CP; Varlotto J
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1048-57. PubMed ID: 22632771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced (stages III and IV) non-small-cell lung cancer.
    Sweeney CJ; Sandler AB
    Curr Probl Cancer; 1998; 22(2):85-132. PubMed ID: 9580849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Cancer: Management.
    Mott TF
    FP Essent; 2018 Jan; 464():27-30. PubMed ID: 29313655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of lung cancer.
    Gadgeel SM; Ramalingam SS; Kalemkerian GP
    Radiol Clin North Am; 2012 Sep; 50(5):961-74. PubMed ID: 22974781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)].
    Eberhardt W; Fietkau R; Griesinger F; Passlick B; Stuschke M
    Onkologie; 2006 Sep; 29 Suppl 2():7-10. PubMed ID: 16974121
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer.
    Meko J; Rusch VW
    Semin Radiat Oncol; 2000 Oct; 10(4):324-32. PubMed ID: 11040333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular diagnostics and imaging].
    Fink C; Fisseler-Eckhoff A; Huss R; Nestle U
    Onkologie; 2009; 32 Suppl 1():3-8. PubMed ID: 19521129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Chemotherapy.
    Hellyer JA; Wakelee HA
    Thorac Surg Clin; 2020 May; 30(2):179-185. PubMed ID: 32327176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.
    Kris MG; Gaspar LE; Chaft JE; Kennedy EB; Azzoli CG; Ellis PM; Lin SH; Pass HI; Seth R; Shepherd FA; Spigel DR; Strawn JR; Ung YC; Weyant M
    J Clin Oncol; 2017 Sep; 35(25):2960-2974. PubMed ID: 28437162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.
    Hanna N; Johnson D; Temin S; Masters G
    J Oncol Pract; 2017 Dec; 13(12):832-837. PubMed ID: 28850309
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future.
    Potti A; Ganti AK
    Expert Opin Biol Ther; 2006 Jul; 6(7):709-16. PubMed ID: 16805710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapies for non-small cell lung cancer.
    Donington JS; Koo CW; Ballas MS
    J Thorac Imaging; 2011 May; 26(2):175-85. PubMed ID: 21508738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based medicine in the treatment of non-small-cell lung cancer.
    Reif MS; Socinski MA; Rivera MP
    Clin Chest Med; 2000 Mar; 21(1):107-20, ix. PubMed ID: 10763093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic strategies in advanced ALK positive non-small cell lung cancer].
    Tiotiu A; Billon Y; Vaillant P; Menard O; Hofman P; Mascaux C
    Rev Mal Respir; 2019 Dec; 36(10):1107-1116. PubMed ID: 31727555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of non-small cell lung carcinoma].
    Souquet PJ
    Rev Prat; 2003 Apr; 53(7):747-51. PubMed ID: 12879798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined-modality therapy for lung cancer].
    Miura S; Yamamoto N
    Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.